Bonnie Gehrke
Primary Care · Casa Grande, AZNPI 1598288144
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 52 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 22.9% — the pattern of someone who eats at a lot of different presentations.
Across 52 payments — averaging $18.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$218
- Lilly USA, LLC$134
- Novo Nordisk$85
- Takeda Pharmaceuticals U.S.A., Inc.$66
- Boehringer Ingelheim$61
- Renalytix AI, Inc.$57
- plus $331 from 16 others
What the payments were for
- Food & beverage$950100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 11 | $218 |
| Lilly USA, LLC | 9 | $134 |
| Novo Nordisk | 4 | $85 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $66 |
| Boehringer Ingelheim | 3 | $61 |
| Renalytix AI, Inc. | 2 | $57 |
| Nevro Corp. | 2 | $48 |
| Pfizer | 2 | $32 |
| Sunovion Pharmaceuticals Inc. | 1 | $28 |
| Astellas Pharma US Inc | 2 | $26 |
| Phadia US Inc. | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $20 |
| Mylan Specialty L.p. | 1 | $19 |
| Johnson & Johnson | 1 | $18 |
| Medtronic | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Exact Sciences | 1 | $16 |
| AstraZeneca | 1 | $15 |
| Abbott | 1 | $15 |
| Cranial Technologies, Inc | 1 | $15 |
| Kaleo, Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
How this compares
$950 in reported general payments places this provider in the 65th percentile of 151 primary care providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $499 |
| Omeprazole | 14 | $241 |
| Lisinopril | 27 | $228 |
| Rosuvastatin Calcium | 20 | $221 |
| Atorvastatin Calcium | 28 | $214 |
| Losartan Potassium | 23 | $190 |
| Levothyroxine Sodium | 43 | $188 |
| Hydrochlorothiazide | 18 | $108 |
| Simvastatin | 15 | $108 |
| Metformin Hcl | 25 | $108 |
| Fluoxetine Hcl | 12 | $86 |
| Metoprolol Tartrate | 12 | $52 |
| Amlodipine Besylate | 11 | $52 |
Paid to pharmacies, not to this prescriber.
Other primary care in Casa Grande
- Trey PowrzanasPhoenix$16K
- Christine Rocks-LopezPhoenix$14K
- Elena KlimovaPhoenix$8K
- Albert VillafaniaPhoenix$8K
- Daniela HaimovPhoenix$8K
- Lea NickolasAvondale$7K
- Neena VargheseSacaton$6K
- Katy DodtQueen Creek$5K
- Mercy GeorgeQueen Creek$5K
- Charity CorreaPhoenix$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.